ITTO20080027A1 - Forma troncata della proteina p17 di hiv. - Google Patents

Forma troncata della proteina p17 di hiv.

Info

Publication number
ITTO20080027A1
ITTO20080027A1 IT000027A ITTO20080027A ITTO20080027A1 IT TO20080027 A1 ITTO20080027 A1 IT TO20080027A1 IT 000027 A IT000027 A IT 000027A IT TO20080027 A ITTO20080027 A IT TO20080027A IT TO20080027 A1 ITTO20080027 A1 IT TO20080027A1
Authority
IT
Italy
Prior art keywords
shaped form
hiv protein
hiv
protein
shaped
Prior art date
Application number
IT000027A
Other languages
English (en)
Inventor
Gianfranco Merizzi
Original Assignee
Medestea Res & Production S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medestea Res & Production S P A filed Critical Medestea Res & Production S P A
Priority to IT000027A priority Critical patent/ITTO20080027A1/it
Priority to CN2008801281861A priority patent/CN101969998A/zh
Priority to EP08871031A priority patent/EP2244732A1/en
Priority to US12/812,747 priority patent/US20100310592A1/en
Priority to RU2010133961/15A priority patent/RU2010133961A/ru
Priority to PCT/IB2008/055341 priority patent/WO2009090512A1/en
Priority to CA2711930A priority patent/CA2711930A1/en
Publication of ITTO20080027A1 publication Critical patent/ITTO20080027A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/625—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier binding through the biotin-streptavidin system or similar
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT000027A 2008-01-15 2008-01-15 Forma troncata della proteina p17 di hiv. ITTO20080027A1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT000027A ITTO20080027A1 (it) 2008-01-15 2008-01-15 Forma troncata della proteina p17 di hiv.
CN2008801281861A CN101969998A (zh) 2008-01-15 2008-12-16 HIV p17蛋白的一种截短形式
EP08871031A EP2244732A1 (en) 2008-01-15 2008-12-16 A truncated form of the hiv p17 protein
US12/812,747 US20100310592A1 (en) 2008-01-15 2008-12-16 A truncated form of the hiv p17 protein
RU2010133961/15A RU2010133961A (ru) 2008-01-15 2008-12-16 Укороченная форма белка p17 вич
PCT/IB2008/055341 WO2009090512A1 (en) 2008-01-15 2008-12-16 A truncated form of the hiv p17 protein
CA2711930A CA2711930A1 (en) 2008-01-15 2008-12-16 A truncated form of the hiv p17 protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000027A ITTO20080027A1 (it) 2008-01-15 2008-01-15 Forma troncata della proteina p17 di hiv.

Publications (1)

Publication Number Publication Date
ITTO20080027A1 true ITTO20080027A1 (it) 2009-07-16

Family

ID=40290383

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000027A ITTO20080027A1 (it) 2008-01-15 2008-01-15 Forma troncata della proteina p17 di hiv.

Country Status (7)

Country Link
US (1) US20100310592A1 (it)
EP (1) EP2244732A1 (it)
CN (1) CN101969998A (it)
CA (1) CA2711930A1 (it)
IT (1) ITTO20080027A1 (it)
RU (1) RU2010133961A (it)
WO (1) WO2009090512A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014113459A1 (en) * 2013-01-15 2014-07-24 Duke University Hiv-1 neutralizing factor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9703802D0 (en) * 1997-02-24 1997-04-16 Kingsman Susan M Anti-hiv peptides and proteins
DE60237373D1 (de) * 2001-08-07 2010-09-30 Medestea Internaz S R L Isolierte polypeptide auf der grundlage des neutralisierenden epitops des p17-proteins vom hiv geeignet als impfstoffe und neutralisierende anti-p17-antikörper, die besagtes epitop spezifisch erkennen
ITTO20020286A1 (it) 2002-03-29 2003-09-29 Medestea Int Spa Uso della proteina p17 isolata per la preparazione di un medicamento atto ad inibire gli effetti immunostimolanti che la proteina prodotta d

Also Published As

Publication number Publication date
US20100310592A1 (en) 2010-12-09
EP2244732A1 (en) 2010-11-03
CA2711930A1 (en) 2009-07-23
CN101969998A (zh) 2011-02-09
WO2009090512A1 (en) 2009-07-23
RU2010133961A (ru) 2012-02-27

Similar Documents

Publication Publication Date Title
SI2126093T1 (sl) Izboljšanje priprave proteinov
BRPI1013688A2 (pt) proteínas de ligação de il-17.
EP2260108A4 (en) PROTEASE TEST
HUE056626T2 (hu) Antitestkészítmény
DE602007001359D1 (de) Saugglocke
EP2215246A4 (en) PROTEIN SCAFFOLDS
DK3118221T3 (da) Proteiner
DK2046826T3 (da) Exendin-fusionsproteiner
BRPI0907237A2 (pt) Anticorpo anti-cldn6
HRP20171011T1 (hr) ANTI-eMET ANTITIJELO
HRP20170138T1 (hr) Ponovno dobivanje proteina
DK2059533T3 (da) Multispecifikke antistoffer
EP2351777A4 (en) ANTI-MUC1 ANTIBODIES
BRPI0820114A2 (pt) Engenharia de proteínas enzimaticamente suscetíveis
DE502008000295D1 (de) Nockenwelle
BRPI0814971A2 (pt) Proteína
SE0702067L (sv) Bestick
BRPI0911578A2 (pt) ensaio de acetaminofeno.
EP2101804A4 (en) PROANGIOGENIC PEPTIDES
IT1394801B1 (it) Struttura di lampada.
ITBO20070832A1 (it) Cotile
IT1394901B1 (it) Struttura di lampada.
DK2238159T3 (da) Hidtil ukendt protein
ITMI20050357A1 (it) Procedimento di preparazione del tazarotene
BRPI1009515A2 (pt) Complexos de proteínas/glicosinolatos eletrostáticos.